REFERENCES
- Pichi F, Ciardella AP, Cunningham ET Jr., et al. Spectral domain optical coherence tomography findings in patients with acute syphilitic posterior placoid chorioretinopathy. Retina (Philadelphia, Pa). 2014;34(2):373–384.
- Drago F, Merlo G, Ciccarese G, et al. Changes in neurosyphilis presentation: a survey on 286 patients. J Eur Acad Dermatol Venereology: JEADV. 2016;30(11):1886–1900.
- Oliver SE, Aubin M, Atwell L, et al. Ocular syphilis: Eight jurisdictions, United States, 2014-2015. MMWR Morb Mortal Wkly Rep. 2016;65(43):1185–1188.
- Workowski KA, Bolan GA. Sexually transmitted diseases treatment guidelines, 2015. MMWR Recomm Rep. Recommendations and reports/Centers for Disease Control. 2015;64(Rr–03):1–137.
- Ghanem KG. REVIEW: neurosyphilis: A historical perspective and review. CNS Neurosci Ther. 2010;16(5):e157–68.
- Eandi CM, Neri P, Adelman RA, Yannuzzi LA, Cunningham ET Jr. Acute syphilitic posterior placoid chorioretinitis: report of a case series and comprehensive review of the literature. Retina (Philadelphia, Pa). 2012;32(9):1915–1941.
- Agostini FA, Queiroz RP, Azevedo DOM, Henriques JF, Campos WR, Vasconcelos-Santos DV. Intravenous ceftriaxone for syphilitic uveitis. Ocul Immunol Inflamm. 2017 May 8:1–7. doi:10.1080/09273948.2017.1311926. [Epub ahead of print]
- Lin P. Infectious uveitis. Curr Ophthalmol Rep. 2015;3(3):170–183.
- Hoogewoud F, Frumholtz L, Loubet P, et al. Prognostic factors in syphilitic uveitis. Ophthalmology. 2017 Aug 2. pii: S0161-6420(17):30925–9. doi:10.1016/j.ophtha.2017.06.003. [Epub ahead of print]